BIO 2024German Exhibitors Priavoid GmbH

Priavoid GmbH

Booth number: 4315-22

About us

Priavoid GmbH is a drug discovery company that was founded in September 2017 as a spin-off from Heinrich Heine University Düsseldorf and Forschungszentrum Jülich. The company develops novel all-D-peptide drug candidates for the treatment of neurodegenerative diseases such as Alzheimer's, Parkinson's, ALS, tauopathies and Huntington's disease. The most advanced candidate is PRI-002 for Alzheimer's disease. All drug candidates are designed for their anti-prionic mode of action. CEO: Philipp Bürling, Supervisory Board: Prof. Dr. Dr. h.c. Detlev Riesner (Chairman), Prof. Dr. Dieter Willbold, Dr. Johannes Schmiegel.


Team Labor

Team Management


Priavoid GmbH
Merowingerplatz 1A
40225 Duesseldorf

Phone:  +49 211 94252298

My German Pavilion

  • Manage your personal profile here and enter your desired business contacts to German companies
  • Keep an eye on the trade fairs, German exhibitors and products that are of interest to you
  • Receive an e-mail notification on relevant upcoming German trade fair presentations
Sign up now